A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/52 (2006.01) A61K 31/675 (2006.01) A61K 31/70 (2006.01) A61K 38/21 (2006.01)
Patent
CA 2147893
The invention is a method for the treatment of humans infected with HBV that includes administering an HBV treatment amount of an enatiomerically pure .beta.-D-dioxolanyl purine nucleoside of formula (I), wherein R is OH, Cl, NH2 or H, and X is selected from the group consisting of alkyl, acyl, monophosphate, diphosphate, and triphosphate, or its pharmaceutically acceptable salt.
Procédé de traitement des malades atteints du virus de l'hépatite B. Il consiste à administrer une dose efficace d'un nucléoside de beta-D-dioxolanyl purine à pureté énantiomère de la formule (I), dans laquelle R représente OH, Cl, NH2 ou H; et X est sélectionné dans le groupe constitué d'alkyle, acyle, monophosphate, diphosphate, triphosphate, ou son sel pharmaceutiquement acceptable.
Emory University
Gowling Lafleur Henderson Llp
LandOfFree
Enantiomerically pure .beta.-d-dioxolane nucleosides with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomerically pure .beta.-d-dioxolane nucleosides with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomerically pure .beta.-d-dioxolane nucleosides with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1480221